Biodelivery Sci Intl (BDSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,138 | -51,196 | -35,219 | -18,733 | -37,672 |
| Depreciation Amortization | 1,408 | 1,053 | 697 | 329 | 1,299 |
| Accounts receivable | -862 | -601 | 80 | 356 | 670 |
| Other Working Capital | -3,580 | -3,213 | -1,818 | -2,462 | 17,892 |
| Other Operating Activity | 16,190 | 12,598 | 7,689 | 3,854 | 14,079 |
| Operating Cash Flow | $-53,982 | $-41,359 | $-28,571 | $-16,656 | $-3,732 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -405 | -316 | -249 | -236 | -701 |
| Investing Cash Flow | $-405 | $-316 | $-249 | $-236 | $-701 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,806 | 2,797 | 2,724 | 2,725 | 756 |
| Other Financing Activity | 40 | 0 | 0 | 0 | 16,765 |
| Financing Cash Flow | $2,846 | $2,797 | $2,724 | $2,725 | $17,521 |
| Beginning Cash Position | 83,560 | 83,560 | 83,560 | 83,560 | 70,472 |
| End Cash Position | 32,019 | 44,682 | 57,464 | 69,393 | 83,560 |
| Net Cash Flow | $-51,541 | $-38,878 | $-26,096 | $-14,167 | $13,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,982 | -41,359 | -28,571 | -16,656 | -3,732 |
| Capital Expenditure | -405 | -316 | -249 | -236 | -701 |
| Free Cash Flow | -54,387 | -41,675 | -28,820 | -16,892 | -4,433 |